- Home
- BGH vs LFCR Comparison
BGH vs LFCR Comparison
Compare BGH & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGH
- LFCR
- Stock Information
- Founded
- BGH 2012
- LFCR 1986
- Country
- BGH United States
- LFCR United States
- Employees
- BGH N/A
- LFCR N/A
- Industry
- BGH Investment Managers
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- BGH Finance
- LFCR Health Care
- Exchange
- BGH Nasdaq
- LFCR Nasdaq
- Market Cap
- BGH 318.8M
- LFCR 308.8M
- IPO Year
- BGH N/A
- LFCR N/A
- Fundamental
- Price
- BGH $16.39
- LFCR $7.46
- Analyst Decision
- BGH
- LFCR Buy
- Analyst Count
- BGH 0
- LFCR 4
- Target Price
- BGH N/A
- LFCR $8.00
- AVG Volume (30 Days)
- BGH 61.5K
- LFCR 103.6K
- Earning Date
- BGH 01-01-0001
- LFCR 10-03-2025
- Dividend Yield
- BGH 10.06%
- LFCR N/A
- EPS Growth
- BGH N/A
- LFCR N/A
- EPS
- BGH N/A
- LFCR N/A
- Revenue
- BGH N/A
- LFCR $128,867,000.00
- Revenue This Year
- BGH N/A
- LFCR $4.78
- Revenue Next Year
- BGH N/A
- LFCR $12.02
- P/E Ratio
- BGH N/A
- LFCR N/A
- Revenue Growth
- BGH N/A
- LFCR 0.47
- 52 Week Low
- BGH $11.92
- LFCR $4.07
- 52 Week High
- BGH $14.50
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- BGH 63.71
- LFCR 49.56
- Support Level
- BGH $15.76
- LFCR $7.33
- Resistance Level
- BGH $16.43
- LFCR $7.78
- Average True Range (ATR)
- BGH 0.14
- LFCR 0.27
- MACD
- BGH 0.01
- LFCR 0.02
- Stochastic Oscillator
- BGH 90.71
- LFCR 45.33
About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests
Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.